Verkkostimuli responsive materials for the controlled delivery of insulin or glucagon are a promising alternative to glucose monitors and insulin pumps.
Verkkothe us food and drug administration (fda) recently approved donislecel, marketed by celltrans inc as lantidra, for the treatment of type 1 diabetes in adults who.
Verkko100 years since the discovery of insulin, this review discusses the current and future treatment strategies for t1dm, many of which are also applicable.